Vaxart, Inc. Deferred Revenue
Vaxart, Inc. (VXRT) had Deferred Revenue of $0 as of 2023-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2025-03-20
- 2023-12-31: Deferred Revenue, Current $0.00.
- 2023-09-30: Deferred Revenue, Current $79.00K.
- 2023-06-30: Deferred Revenue, Current $275.00K.
- 2023-03-31: Deferred Revenue, Current $1.60M.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2025-03-20 | |
| 2023-09-30 | $79.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $275.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $1.60M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $2.00M 10-K · filed 2024-03-14 | |
| 2022-11-30 | $2.00M 10-Q · filed 2024-08-08 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-15 | |
| 2018-12-31 | $3.33M 10-K · filed 2019-02-06 | |
| 2018-09-30 | $3.28M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $3.15M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $2.04M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.20M 10-Q · filed 2018-02-06 | |
| 2017-09-30 | $1.50M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.40M 10-Q · filed 2018-02-06 | |
| 2017-03-31 | $400.00K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $1.20M 10-Q · filed 2017-02-06 | |
| 2016-09-30 | $1.20M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $1.30M 10-K · filed 2017-09-01 | |
| 2013-09-30 | $100.00K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $300.00K 10-K · filed 2014-09-30 | |
| 2013-03-31 | $650.00K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $881.00K 10-Q · filed 2013-02-11 | |
| 2012-09-30 | $2.53M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $400.00K 10-K · filed 2013-09-27 | $2.53M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $2.53M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $2.53M 10-Q · filed 2012-11-08 | |
| 2011-09-24 | $2.53M 10-Q · filed 2011-11-02 | |
| 2011-06-25 | $2.53M 10-Q · filed 2011-08-03 | |
| 2010-12-25 | $7.80M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |